Purdue Pharma Wins Bankruptcy Approval in Opioid Case
Purdue Pharma receives court approval for $7.4 billion opioid settlement after Supreme Court intervention. Sackler family to pay $6.5 billion over 15 years in landmark case.
Category : Search result: Vanda Pharma FDA approval
Purdue Pharma $7B Opioid Settlement Gets Court Nod
Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
FDA Names Dr. Richard Pazdur as New Drug Center Director
The FDA appoints veteran cancer regulator Dr. Richard Pazdur to lead its drug center following the ouster of Dr. George Tidmarsh over ethics concerns. Learn about the challenges ahead.
ByHeart Recalls All Infant Formula Over Botulism Fears
ByHeart voluntarily recalls all infant formula nationwide after FDA reports 13 infants consumed their products amid botulism outbreak. No deaths reported. Immediate disposal advised.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
FDA OKs Linzess for Kids with IBS-C - First Pediatric Treatment
In a groundbreaking medical advancement, the FDA has approved Linzess (linaclotide) for children aged 7+ with IBS-C, offering the first dedicated treatment for pediatric constipation and abdominal pain.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Bengaluru Pharmacies Sell Mislabeled ORS - Health Risk
Shocking investigation reveals Bengaluru pharmacies continue to sell inaccurately labeled Oral Rehydration Solution, putting children's health in danger despite regulatory warnings.
FDA restricts children's supplement over health concerns
The US FDA has issued strict restrictions on a widely-used supplement for growing children after discovering serious health concerns. Find out which common product is now under scrutiny and what parents need to know.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Goa FDA cracks down on Calangute food safety violations
Goa's Food and Drug Administration launches strict enforcement drive against hygiene violations in Calangute's restaurants and food establishments following tourist complaints.
FDA Approves Oral Weight Loss Drug Rybelsus
Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.
FDA Recalls Blood Pressure Meds Over Cancer Risk
Multiple blood pressure medications recalled after FDA detects potential cancer-causing impurities. Find out if your medication is affected and what steps to take immediately.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
FDA OKs Pill That Prevents Heart Attacks by Reducing Inflammation
Discover the groundbreaking FDA-approved medication that reduces cardiovascular risks by tackling chronic inflammation, offering new hope for millions at risk of heart attacks and strokes.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
FDA Recalls 580K Blood Pressure Meds Over Cancer Risk
Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.
Page 3 of 4